Back to User profile » Dr Stefan Walzer

Papers published by Dr Stefan Walzer:

Original Research

Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer

Vergnenègre A, Ray JA, Chouaid C, Grossi F, Bischoff HG, Heigener DF, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:31-37

Published Date: 26 January 2012

Original Research

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Gerald HJ Mickisch, Björn Schwander, Bernard Escudier, et al

ClinicoEconomics and Outcomes Research 2011, 3:19-27

Published Date: 25 January 2011